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Abstract
Background: Leptin is a peptide hormone playing pivotal role in regulating food intake and energy expenditure. Growing
evidence has suggested the pro-inflammatory and fibrogenic properties of leptin. In addition, patients with renal fibrosis
have higher level of plasma leptin, which was due to the increased leptin production. Aristolochic acid (AA) is a botanical
toxin characterized to associate with the development of renal fibrosis including tubulointerstitial fibrosis. However,
whether leptin is upregulated to participate in AA-induced kidney fibrosis remain completely unknown.
Methodology/Principal Findings: In this study, leptin expression was increased by sublethal dose of AA in kidney fibroblast
NRK49f determined by enzyme-linked immunosorbent assay and Western blot. Data from real-time reverse transcriptase-
polymerase chain reaction revealed that leptin was upregulated by AA at transcriptional level. DNA binding activity of
CCAAT enhancer binding protein a (C/EBP a), one of the transcription factors for leptin gene, was enhanced in DNA affinity
precipitation assay and chromatin immunoprecipitation experiments. Knockdown of C/EBP a expression by small interfering
RNA markedly reduced AA-induced leptin expression. Moreover, AA promoted Akt interaction with p-PDK1, and increased
phosphorylated activation of Akt. Akt knockdown, and inhibition of Akt signaling by LY294002 and mTOR inhibitor
rapamycin reduced leptin expression. Furthermore, treatment of LY294002 or rapamycin significantly suppressed AA-
induced C/EBP a DNA-binding activity. These results suggest that Akt and C/EBP a activation were involved in AA-regulated
leptin expression.
Conclusions/Significance: Our findings demonstrate the first that AA could induce secretion and expression of fibrogenic
leptin in kidney fibroblasts, which reveal potential involvement of leptin in the progression of kidney fibrosis in aristolochic
acid nephropathy.
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Introduction
Leptin, an obese gene (ob) product initially identified in 1994,
was named from the Greek word leptos, which means thin [1].
Leptin is a 16 kDa peptide hormone of cytokine family mainly
secreted by adipocyte into blood stream and functions as a central
mediator that negatively regulates satiety in hypothalamus, while
its deficiency is associated with the development of obesity and
metabolic syndrome [2]. However, the subsequent discovery of
leptin receptor expression beyond brain tissue such as lung, liver
and kidney implicates its action other than appetite regulation and
energy metabolism [3,4]. Growing evidences suggest the fibro-
genic property of leptin. For example, mice receiving recombinant
leptin enhanced fibrogenic response, while leptin receptor-
deficient fa/fa rat and db/db mice are resistant to the development
of liver fibrosis [5,6]. The secretion of fibrogenic transforming
growth factor-b (TGF-b) is enhanced by exogenous addition of
leptin in cultured glomerular endothelial cells [7]. In rodent model
of renal interstitial fibrosis, elevated TGF-b mRNA level,
phosphorylated activation of Smad 2/3 and the up-regulated
downstream target genes are significantly reduced in leptin
deficient ob/ob mice [8]. Leptin was further considered as a
cofactor of TGF-b activation, which enhanced TGF-b signaling in
normal rat kidney fibroblasts [8]. These results implicate the
regulatory role of leptin in renal interstitial fibrosis.
Aristolochic acid (AA) is a famous botanical toxin which has
been characterized to associate with the development of
aristolochic acid nephropathy (AAN). AAN, previously designated
as Chinese-herb nephropathy (CHN), was originally reported in a
group of women in Belgium who receiving sliming pills containing
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AA [9]. These patients suffered from progressive interstitial fibrosis
leading to end-stage renal disease, the stage that kidney
permanently fails to work [9]. Besides, experimental AAN was
also characterized to induce interstitial fibrosis after injection of
AA to Wistar rats [10,11].
Renal interstitial fibrosis is the process of renal fibroblasts activation
and accumulation. The activated fibroblasts, myofibroblasts, are the
main source of extracellular matrix deposition [12,13]. Fibroblasts, a
part of the interstitial connective tissue, are one of the important
sources for cytokine synthesis and action which may result in fibrosis
[14]. Since leptin belongs to a peptide hormone of cytokine family, and
enhanced leptin expression by insulin stimulation has been reported in
human skin fibroblasts [14]. In addition, patients with end-stage renal
disease have higher level of plasma leptin, which was due to the
increased leptin production [15]. Thus far, leptin has been considered
to play an important role in progressive renal fibrosis. Renal fibroblast,
in particular under the progression of fibrosis induced by AA, has not
been intensively investigated with regard to biosynthesis and secretion
of leptin. Therefore, the aim of this study is to explore the effect of AA
on leptin production and to dissect the AA-induced downstream
signaling in vitro. We found that AA could upregulate leptin in rat renal
fibroblast NRK-49f cells through an Akt-C/EBP a signaling pathway.
These findings imply the fibroblast-produced leptin maybe one of the
factor which promotes the progression of renal fibrosis induced by AA.
Results
AA increased leptin expression in renal NRK-49f
fibroblasts
Rat renal fibroblast NRK-49f cells were treated with different
doses of AA for 48 h. As shown in Fig. 1A, low doses of AA
(3,12 mM) did not affect the growth of NRK-49f cells, whereas
high dose of AA (50 mM) exhibited a strong antiproliferative effect,
with approximately 50% growth inhibition, detected after 48 h
incubation (Fig. 1B and 1C). Therefore, the low doses (!12 mM) of
AA were chosen for the following experiments of detecting cellular
and molecular events. To examine whether AA affected leptin
production, NRK-49f cells were treated without or with 6 and
12 mM AA for 24 and 48 h. Significant elevation of leptin secretion
was observed in AA-treated cells compared to untreated controls,
particularly at 48 h of 12 mM AA treatment (p=0.0083) (Fig. 2A).
Data from Western blot analysis showed that AA exposure led to an
increase in the level of leptin protein in NRK-49 cells (Fig. 2B). To
address whether the AA-induced leptin production might result
from a transcriptional regulation, NRK-49f cells were stimulated
without or with AA for 12 and 24 h, and the level of cellular leptin
mRNA was measured by reverse transcriptase-polymerase chain
reaction (RT-PCR) and real-time PCR (Fig. 2C & 2D). As
presented in Fig. 2D, the amounts of leptin mRNA rose markedly
afterAAtreatments.Theseresultsindicate thattheleptin expression
would be enhanced by AA at transcriptional level.
The involvement of transcription factor C/EBP a in AA-
induced leptin expression
C/EBP a has been reported as a key transcription factor
implicated in the determination of the adipocyte differentiation
which regulates leptin gene expression [16]. Therefore we
examined the effects of AA on the activity and expression of C/
EBP a. DNA affinity precipitation assay (DAPA) using nuclear
extracts from NRK-49f cells and an oligonucleotide probe
corresponding to a consensus binding site of C/EBP a generated
a specific protein-oligonucleotide complex. As shown in Fig. 3A,
the DNA binding activity of C/EBP a was enhanced dose-
dependently upon AA treatment compared to controls. Neverthe-
less, the level of C/EBP a protein per se was not regulated by AA
(Fig. 3B). Knockdown of C/EBP a expression with specific siRNA
(Fig. 3B) suppressed AA-induced leptin secretion (Figs. 3C). These
results suggested the involvement of C/EBP a in AA-mediated
upregulation of leptin.
Activation of PI3K-Akt signaling pathway by AA
Leptin production has been reported to be upregulated through
PI3K-Akt-mTOR pathway in adipocytes [17]. To examine
whether AA activated PKB/Akt, we performed Western blotting
of lysates from untreated or AA-treated NRK-49f cells using
antibodies against phospho-PKB/Akt. Elevated levels of Akt-
Ser473 phosphoproteins were detected in AA-treated cells
Figure 1. The effect of aristolochic acid on cell growth of NRK-49f cells. NRK-49f cells were treated with 0, 3, 6, 12, 25 and 50 mM of AA for
48 h. (A) Cell morphology was investigated by phase-contrast microscopy. Magnification 100X. Scale bar, 50 mM. (B) The cell survival rate was
determined by MTT assay, and (C) the cell proliferation was examined by BrdU incorporation. Data are presented as mean6S.D. of 9 replicates from
three independent experiments.
doi:10.1371/journal.pone.0016654.g001
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The level of secreted leptin was measured by ELISA. Data are presented as mean6S.D. of 9 replicates from three independent experiments. (B) Leptin
expression was examined by Western Blot. NRK-49f kidney fibroblasts were treated without or with 12 mM AA for 24 and 48 h. (C) Expression of leptin
mRNA. Fibroblasts were treated with 0, 6 and 12 mM AA for 12 and 24 h, the level of leptin mRNA was determined by RT-PCR and (D) real-time PCR.
doi:10.1371/journal.pone.0016654.g002
Figure 3. Involvement of C/EBP a in aristolochic acid-induced leptin expression. (A) Enhancement of C/EBP a DNA binding activity by AA.
Fibroblasts were treated with 0, 6 and 12 mM AA for 3 h, nuclear extracts were isolated and C/EBP a DNA binding activity was analyzed by DAPA. (B)
Knockdown of C/EBP a expression by siRNA. NRK-49f cells were transfected with 0, 90 and 180 nM of C/EBP a siRNA or control scramble siRNA for 8 h,
and then cells were treated with 12 mM AA for another 48 h, the expression level of C/EBP a was examined by immunoblotting (upper panel) and RT-
PCR (lower panel). (C) The secreted leptin was measured by ELISA. Data are presented as mean6S.D. of 9 replicates from three independent
experiments.
doi:10.1371/journal.pone.0016654.g003
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upstream molecules mediating Akt activation were proposed to
be the phosphorylation of PI3K and PDK1 [18]. The phosphor-
ylation of PDK1 and PI3K p85 respectively at Ser241 and Tyr458
are required for their kinase activity [19,20,21], which were also
elevated upon AA stimulation (Fig. 4B). In addition, the
interaction of p-PDK1 with Akt due to the phosphorylation
activation by AA treatment was further confirmed by immuno-
precipitation (IP) experiment (Fig. 4C), suggesting that AA
triggered PI3K-Akt signaling activation in NRK-49f cells.
Involvement of Akt and mTOR in AA-induced leptin
expression
To assess the role of PI3K-Akt signaling in AA-induced leptin
expression, endogenous Akt was knockdowned by specific siRNA,
which reduced both cellular Akt expression and AA-induced Akt
phosphorylation (Fig. 5A). Suppression of AA-induced leptin
secretion was observed in Akt-knockdowned cells (Fig. 5B).
Previous report indicates that leptin synthesis is positively
regulated by mTOR which is a downstream target of Akt [22].
Hence, we further examined the role of mTOR in AA-mediated
leptin expression. Rapamycin was reported to be an inhibitor of
mTOR complex 1 (mTORC1) and even mTOR complex 2
(mTORC2), which are the downstream and upstream regulator of
Akt respectively [18,23,24]. Here, we found that AA-induced
phosphorylation of Akt was reduced by rapamycin, as well as
LY294002 (Fig. 5C). Moreover, inhibition of AA-stimulated leptin
secretion was observed by treatment of NRK-49f cells with
LY294002 (p=0.0353) or rapamycin (p=0.0476) (Fig. 5D). In
addition, AA-induced leptin expression was also abolished by the
prior treatment of LY294002 or rapamycin (Fig. 5E). Further-
more, addition of LY294002 or rapamycin appeared to signifi-
cantly inhibit the expression of leptin mRNA (Fig. 5F).
To address whether PI3K-Akt signaling pathway plays a role in
C/EBP a transactivation upon AA treatment, NRK-49f cells were
pretreated with LY294002 and rapamycin prior to AA. Addition
of 10 mM LY294002 or 50 nM rapamycin abrogated AA-
mediated C/EBP a DNA binding activity in the result of DAPA
(Fig. 6A). Data of chromatin immunoprecipitation assay (ChIP)
further confirmed that inhibition of PI3K-Akt signaling by
LY294002 and rapamycin significantly inhibited intracellular C/
EBP a-DNA binding induced by AA (Fig. 6B). These results
showed AA-induced transactivation of C/EBP a was mediated via
activation of the PI3K-Akt pathway.
Discussion
AA, a nephrotoxic and carcinogenic plant alkaloid which is
derived from Aristolochia species, could be a potential etiological
factor for progressive renal interstitial fibrosis frequently associated
with urothelial malignancies [25]. Renal interstitial fibrosis is the
process of renal fibroblasts activation and accumulation. The
activated fibroblasts, myofibroblasts, are the main source of
extracellular matrix deposition. In particular, fibroblasts are one
of the important sources for cytokine synthesis and action which
may result in inflammation and fibrosis. However, renal fibroblasts
have not been intensively investigated with regard to biosynthesis
and secretion of leptin.
In this study, we found that the sublethal doses of AA increased
the leptin expression in rat renal fibroblast NRK-49f cells at a
transcriptional level. Leptin is a peptide hormone mainly produced
by adipose tissue. However, recent evidence has shown that the
placenta, skeletal muscle, and possibly stomach fundus are
additional sites of leptin synthesis [26,27]. Besides its effects on
regulation of body weight, appetite and energy expenditure, leptin
also exhibits influence on the immune system and may contribute
to the deterioration of renal function. The peptide stimulates
proliferation of glomerular endothelial cells, and increases TGF-b1
synthesis as well as collagen type IV production [7]. Leptin also
increases collagen type I and surface TGF-b type II receptor
synthesis in mesangial cells [28]. Infusion of leptin into normal rats
fosters development of glomerulosclerosis and proteinuria [7]. In
addition, leptin may stimulate profibrotic action in the kidney by
sympathetic overactivity which has been associated with the
progression of renal disease [29,30]. These findings collectively
suggest that the kidney is a target organ for leptin and that this
peptide hormone might play an important role in renal
pathophysiology. Our observations showed firstly that AA could
upregulate the expression of the fibrosis-associated peptide
hormone leptin in renal fibroblasts.
The regulation of leptin biosynthesis and secretion by AA in
renal fibroblasts has not been studied yet. It has been reported that
the promoter region of leptin gene contains transcription response
elements including a TATA box, a CCAAT/enhancer binding
protein (C/EBP) element, a leptin promoter specific factor (LP1)
and a Sp1 site [31]. Point mutation of those conserved and
functional regions respectively reduced promoter activity in rat
adipocytes. In the results of both DAPA and ChIP, C/EBP a-
DNA binding activity was induced by AA, whereas the assays
Figure 4. PI3K-Akt signaling pathway was activated upon AA treatment. (A) Examination of Akt activation. NRK-49f cells were incubated
with 0 and 12 mM AA for 1, 3 and 6 h. The phosphorylated activation form of Akt was detected by immunoblotting. (B) The levels of phosphorylated
PDK1 and PI3K-p85 were evaluated by Western Blot at indicated periods of AA treatment. (C) The interaction of phosph-PDK1 with Akt. After 1 h of 0
and 12 mM AA treatments, cells were immunoprecipitated with anti-Akt antibody. The immunoprecipitated pellets were further immnoblotted with
anti-phospho PDK1 or anti-Akt antibody. The input and mouse IgG were served as positive and negative control, respectively.
doi:10.1371/journal.pone.0016654.g004
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obvious variation compared with the control (data not shown). C/
EBP a is a basic region/leucine zipper transcription factor
important for the transcription of most adipocyte genes and of
other genes involved in energy metabolism [32]. Previous studies
show that C/EBP a has been identified as a transactivator of the
leptin promoter working through a consensus C/EBP binding site
in the proximal leptin promoter [16,33]. This site mediates
activation of the leptin promoter by co-transfected C/EBP a in
primary rat adipocytes and 3T3-L1 preadipocytes [16,34]. Here,
we showed that knockdown of C/EBP a by siRNA effectively
reduced AA-induced leptin secretion, which indicated the
involvement of C/EBP a in AA-regulated leptin expression in
renal fibroblasts. The identification of C/EBP a in the upregula-
tion of leptin expression induced by AA raises an obvious question.
Does regulation of leptin expression by AA occur via modification,
Figure 5. Involvement of PI3K-Akt signaling pathway in AA-induced elevation of leptin expression and C/EBP a DNA binding
activity. (A) Knockdown of Akt by siRNA. Cells were transfected with 0, 60 and 120 nM of Akt siRNA or control scramble siRNA for 8 h, and then cells
were treated with AA for another 48 h, the expression level of Akt was examined by immunoblotting (upper panel) and RT-PCR (lower panel). (B)
Leptin secretion. Akt siRNA-transfected NRK-49f cells were treated with 12 mM AA for 48 h. The secreted leptin was measured by ELISA. (C) Analysis of
Akt activation. Cells were pretreated with 10 mM LY294002 (PI3K inhibitor) or 50 nM rapamycin (mTOR inhibitor) 1 h prior 12 mM AA addition. After
3 h incubation, level of Akt phosphorylation was determined by immunoblotting. (D) Analysis of leptin expression. Cells were treated with PI3K-Akt
signaling inhibitors, LY294002 or rapamycin for 1 h, and were followed by 48 h of AA administration. Level of leptin secretion and protein expression
were measured by (D) ELISA and (E) immunoblotting, respectively. (F) Expression of leptin mRNA. After the 1 h pretreatment of indicated inhibitors,
cells were then treated with AA for another 24 h. RNA was isolated, and the level of leptin mRNA was assessed by RT-PCR.
doi:10.1371/journal.pone.0016654.g005
Figure 6. Involvement of PI3K-Akt signaling in the C/EBP a transactivation. Determination of C/EBP a DNA binding activity. After 1 h
administration of LY294002 and rapamycin, NRK-49f cells were treated without or with 12 mM AA for 3 h. The DNA binding activity of C/EBP a was
examined by (A) DAPA and (B) ChIP.
doi:10.1371/journal.pone.0016654.g006
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promoter? Our observations indicated that phosphorylation, but
not expression, of C/EBP a is regulated by AA.
Several studies have demonstrated insulin-mediated increases in
leptin gene transcription and synthesis [35,36,37]. Inhibitors of
PI3K and MEK1/MEK2, as well as mTOR, had been showed to
block insulin stimulated leptin release from isolated rat adipocytes
[38]. A previous report indicated that leptin synthesis is regulated
by PI3K, Akt and mTOR [22]. Here, we found that the leptin
gene expression induced by AA in renal fibroblasts was regulated
through activated PDK1, Akt and mTOR. However, the
downstream signaling of mTOR that leads to a specific increase
in leptin expression remains to be determined. AMP-activated
protein kinase (AMPK) is an enzyme that works as a fuel gauge
which becomes activated in situations of energy consumption.
AMPK functions to restore cellular ATP levels by modifying
diverse metabolic and cellular pathways [39]. Overexpressing
dominant negative AMPK had been demonstrated to increase
mTORC1 and leptin translation [40]. However, in this study, the
level of phosphorylated activation of AMPK at T172 site was not
affected by AA treatment (data not shown), suggesting that AMPK
was not involved in regulation of leptin expression upon AA
treatment in renal fibroblasts.
Our observations do not provide the direct evidence to
demonstrate how AA transduced the downstream signaling to
the cells. It has been reported that the uptake of AA is indicated by
the anion transporter (OAT) in kidney proximal cells [41,42]. AA
exhibited high affinity to OAT1, as well as OAT3, while the OAT-
mediated AA uptake was abolished in the presence of the OAT
inhibitor probenecid [41,42]. Hence, whether OATs exist and
involve in the biological effects of AA in renal fibroblasts requires
further investigation.
Taken together, our findings demonstrate that leptin synthesis
and secretion were upregulated by AA through PI3K-Akt and C/
EBP a activated pathway in renal fibroblasts, which might
contribute to the progression of kidney fibrosis in aristolochic
acid nephropathy.
Materials and Methods
Materials
1:1 mixture of AA I and II and rapamycin were obtained from
Calbiochem (CN Biosciences Notts, UK). 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) and C/EBP a
small interfering RNA (siRNA) were purchased from Sigma (St.
Louis, MO, USA). Cell proliferation (BrdU) kit was purchased
from Roche Applied Science (Mannheim, Germany). Rat leptin
ELISA kit was purchased from Millipore (Bedford, MA). Anti-
leptin antibody, anti b-actin antibody, anti-C/EBP a antibody,
anti-Akt antibody and Akt siRNA were obtained from Santa Cruz
(Santa Cruz, CA, USA). Anti-p-Akt
S473 antibody, anti-p-Akt
T308
antibody, anti-p-PDK1
S241 antibody, anti-p-PI3K p85
Y458 and
LY294002 were purchased from cell signaling technology (Beverly,
MA).
Cell culture
Rat kidney fibroblast NRK-49f cell line was obtained from
American Type Culture Collection. Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
5% bovine serum (GIBCO), 1% non-essential amino acid,
penicillin (100 unit/ml), and streptomycin (100 mg/ml). Bovine
serum was reduced to 0.5% in the treatment of AA. Cells were
incubated in 95% air, 5% CO2 humidified atmosphere at 37uC.
AA was prepared with DMSO, and the control studies were
performed using equivalent DMSO volume compared to the
highest AA dose, which was calculated to be maximal 0.05%
DMSO in the culture medium.
Cell viability and BrdU incorporation assay
Cell viability and proliferation were assessed by the mitochon-
drial-dependent reduction of MTT to purple formazan and BrdU
incorporation respectively. After culture of overnight in a 12-well
plate, NRK-49f cells (1610
4 cells/well) were treated with 0, 3, 6,
12, 25 and 50 mM of AA. After 48 h treatment, MTT solution
(100 mg/well) was added for another 2 h. The medium was
removed and 200 ml of DMSO was added to each well and then
vibrated for 10 min. Absorbance at 550 nm was measured using a
microplate reader. The percentage of viable cells was calculated as
follows: (absorbance of experimental group/absorbance of control
group) x 100%. In the experiment of cell proliferation assay,
3610
5/well of cells seeded in 96-well plate were treated without or
with AA for 48 h. BrdU incorporation and detection were in
accordance with the manufacturer’s instructions.
Measurement of leptin secretion
Secreted leptin was collected from the 10 ml medium of 2–
3610
6 cells, and was concentrated with Amicon Ultra-4
centrifugal filter devices (Millipore, Bedford, MA) at 4uC. The
amount of leptin secretion into the culture medium was
determined by enzyme-linked immunosorbent assay (ELISA)
using a commercially available rat leptin ELISA kit (Millipore,
Bedford, MA) according to the protocol recommended by the
manufacturer. The secreted leptin level detected from each
treatment had been normalized to 1610
6 cells in 1 ml medium.
Western blot analysis
Cells were lysed at 4uC in RIPA buffer containing 50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.25% Sodium
deoxycholate, 5 mM EDTA (pH 8.0), and 1 mM EGTA and
supplemented with protease and phosphatase inhibitors. After
20 min of lysis on ice, cell debris was removed by microcen-
trifugation, followed by quick freezing of the supernatants. The
protein concentration was determined by Bradford method. In our
experiments, 25–50 mg of protein was loaded. In particular for the
phosphorylated protein detection, 100 mg of protein was loaded.
Equal amounts of proteins were separated by SDS-polyacrylamide
gels and then electrophoretically transferred from the gel onto a
PVDF membrane (Millipore, Bedford, MA). After blocking with
5% non-fat milk, the membrane was reacted with specific primary
antibodies overnight at 4uC and then incubated with horseradish
peroxidase conjugated secondary antibody for 1 h. The blots were
visualized using ECL-Plus detection kit (PerkinElmer Life
Sciences, Inc. Boston, MA, USA). The blot images were
quantitated by densitometry using the GelPro analysis software
and normalized with the internal control (b-actin).
Semi-quantitative RT-PCR and real-time PCR
Total cellular RNA was extracted by RNA-Bee
TM RNA
isolation kit (TEL-TEST, Friendswood, TX) in accordance with
the manufacturer’s instructions. One microgram of total RNA was
reverse-transcribed using Advantage RT for PCR Kit (Clontech,
Mountain View, CA) at 42uC for 1 h as described in the
manufacturer’s protocol. PCR conditions for rat leptin were 94uC
for 5 min and 37 cycles at 94uC for 30 s, 56uC for 30 s and 72uC
for 60 s, followed by a final extension step at 72uC for 5 min by
Bio-Rad icycle (Bio-Rad). Primer sequences were as follows: rat
leptin: 59-CCAGGATGACACCAAAACCC-39 (sense) and 59-
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size of 405 bp; rat b-actin: 59- TCTACAATGAGCTGCGTGTG-
39 (sense) and 59-GGTCAGGATCTTCATGAGGT-39 (antisense)
with product size of 314 bp. For each combination of primers, the
kinetics of PCR amplification was studied. The number of cycles
corresponding to plateau was determined and PCR was performed
at exponential range. PCR products were then electrophoresed
through a 1% agarose gel and visualized by ethidium bromide
staining in UV irradiation. The mRNA levels were also determined
byreal-timePCRwithABIPRISM7900SequenceDetectorsystem
according to the manufacturer’s instructions. b-actin was used as
endogenous control. PCR reaction mixture contained the SYBR
PCR master mix (Applied Biosystems), cDNA, and the primers.
Relative gene expression level (the amount of target, normalized to
endogenous control gene) was calculated using the comparative Ct
method formula E
-DDCt. The primer sequences were as follows: rat
leptin: 59-CTGTGGCTTTGGTCCTATCT-39 (sense) and 59-
TCCATCTTGGACAAACTCAG-39 (antisense).
Small interfering RNA (siRNA) transfection
Cells were seeded in 6-well plates and transfected with Akt or C/
EBP a specific siRNA using Lipofectamine 2000 (Invitorgen) in
accordance with the manufacturer’s instructions. After 6 h of
incubation, the medium was replaced with complete medium. Rat
C/EBP a (SASI_Rn01_00034372) and Akt siRNA (SA-
SI_Rn01_00063656) were purchased from sigma, and control siRNA
(sc-37007) was purchased from Santa Cruz. siRNA sequences were as
follows: rat C/EBP a:5 9-GCCUGAGAGCUCCUUGGUC-39
(sense) and 59-GACCAAGGAGCUCUCAGGC-39 (antisense); rat
Akt1: 59-GGCACAUCAAGAUAACGGA-39 (sense) and 59-UCC-
GUUAUCUUGAUGUGCC-39 (antisense). Sequences of control
siRNA were not released from the manufacturer.
Immunoprecipitation
Cells were washed with PBS. The lysate was prepared by adding
1 ml of immunoprecipitation assay buffer (50 mM Tris-HCl,
pH 7.8, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 0.5%
Nonidet P-40, 0.1% deoxycholate, and 10 mg/ml each of leupeptin,
aprotinin, and 4-(2-aminoethyl)benzenesulfonyl fluoride) to the
cells. Then the lysate was centrifuged using a microcentrifuge at
10,000 rpm for 20 min. The supernatant was precleaned with
Protein A/G Plus-Agarose beads (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and followed centrifugation. Anti-Akt antibody
was added to the supernatant at 4uC for overnight. Protein-A/G-
agarose beads were added to the lysate, and the mixture was
incubated with shaking for 1 h at 4uC. The beads were finally
collected by centrifugation and washed three times with immuno-
precipitation assay buffer. Proteins binding to the beads were eluted
by adding 20 ml of 2X electrophoresis sample buffer and analyzed
by immunoblotting with anti-phospho PDK1 antibody.
DNA affinity precipitation assay (DAPA)
DNA affinity precipitation assay was carried out by immobiliz-
ing 1 mg of the biotinylated probe per sample onto strepatvidin-
agarose beads (Invitrogen), as recommended by the manufacturer.
Nuclear extracts from indicated time points and treatments were
precleaned with streptavidin-agarose beads for 1 h, with gentle
rotation at 4uC. After centrifugation, the supernatants were
incubated with biotinylated probe in binding buffer [150 mM
KCl, 12 mM Hepes (pH=7.9), 4 mM Tris–HCl (pH=7.9), 12%
(v/v) glycerol, 1 mM EDTA, 1 mM dithiothreitol] for overnight.
Streptavidin-agarose beads were added, and incubated for 1 h
with gentle rotation at 4uC. The precipitated DNA-protein
complexes were then washed three times with binding buffer,
resolved on SDS-polyacrylamide gel electrophoresis, and detected
by western blot using anti-C/EBP a specific antibody.
Chromatin immunoprecipitation (ChIP) assay
NRK-49f cells were subjected to various treatments as indicated
in the figure. The cells were then fixed with 1% formaldehyde at
37uC for 10 min. Cells were collected by centrifugation in PBS
containing protease inhibitors and were lysed in SDS-lysis buffer
followed by the ChIP assay as described previously [43].
Immunoprecipitation was performed overnight with antibodies
against C/EBP a. After immunoprecipitation, 60 ml of salmon
sperm DNA-protein A agarose was added for 1 h at 4uCt o
capture the immune complexes. The agarose beads were washed,
chromatin extracted and protein-DNA cross-links reversed. DNA
was purified by DNA clean-up purification Kit (Promega) and was
analyzed by RT-PCR analysis. The primer sequences were as
follows: 59-GATTACCCGGCTCATACCAA-39 (sense) and 59-
GCACCAAGCTGTCCACACTA-39 (antisense) with product
size of 381 bp.
Statistical analysis
All data are presented as mean6S.D. Statistical analysis used
Student’s t-test for pairs with the following significance levels:
* P,0.05, ** P,0.01, *** P,0.001. All figures were generated
from at least three repeated experiments with similar patterns.
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